Grant Applications
The Research Grant program assists investigators, new or established, who have research projects for which they need support. While the OHF primarily seeks to fund grants which will increase the understanding of Primary Hyperoxaluria and oxalosis and improve the clinical management and treatment of the genetic diseases, applications focused on hyperoxaluria and oxalosis associated with other conditions and diseases will also be considered.

Support: Applications for up to two years of support will be considered. These funds may be used in the following categories: Personnel, Supplies, Other Costs, Travel, and Equipment. Indirect costs up to 10% of the direct costs (excluding equipment) may be requested.

Please be sure to check our News Page for grant-related announcements.

2009 Announcement of Request for Proposals

• MAXIMUM FUNDING: $160,000.00 for up to two years. Indirect costs must be included in the maximum funding amount.
• Deadline for Submission: September 15, 2009
  (has been extended to October 15, 2009 for 2009 ONLY)
• Notification of Award: February 1, 2010
• Funding Begins: Within 9 months of award
• Guidelines for Submission of Applications
• Award Notifications
• OHF Research Grant Application
• Re-submissions

 

1. All completed applications must be submitted electronically to grantapp@ohf.org in Microsoft Word Format. Applications must be typed, single spaced, 11 pt Times-Roman font with at least one-inch margins. Appendices must be in Adobe Acrobat format (version 5.0 or higher).

Mail the original, signed application with all attachments to Kim Hollander at OHF by midnight on September 15, 2009 (has been extended to October 15, 2009 for 2009 ONLY). Late applications post-marked after the deadline, will not be accepted. The receipt deadline will not be waived.

Application email:	grantapp@ohf.org
Application address:	Kim Hollander Executive Director OHF 201 East 19th Street, Suite 12E New York, New York 10003

2. A short paragraph should be included in the General Objectives and Rational section describing the relevance of the proposed research to the goals of the OHF which are to find a cure for oxalosis, Primary Hyperoxaluria, and related stone diseases and to improve the care and treatment of those it affects.

3. Please review the entire application form before completing. The first step in using the application is to enter your name in the "document author" field, so it will be propagated into the heading on all pages. Follow these steps to fill in the document author field:

1. Open the application and pull down the "File" menu. Select "Properties".
2. Click the Summary tab and enter your name into the "Author" field. Note: Enter your name surname first, first name last (e.g. Smith, Jane)
3. Click OK and save the application.

4. Pages 1-8 are to be completed by all applicants. The Principal Investigator must sign the Assurance statement at the bottom of page 6 for the application to be reviewed.

Applicants will be notified in writing regarding the status of their applications. Notification for Research Grants will be sent by February 1, 2010. PLEASE DO NOT CALL TO REQUEST COMMENTS OR TO ASCERTAIN WHETHER OR NOT THE GRANT HAS BEEN FUNDED. (Please Note: It is the responsibility of the Applicant to notify his/her institution of any OHF Award.)

MS Word file - Grant Application

OHF-Grant-e-Application.doc

  Contains an MS-Word document.

 

Acrobat File - Grant Application Instructions Only

OHF-Grant-Application-Instructions.pdf

  Instructions in Adobe Acrobat Format

The OHF encourages grant re-submissions of revised grants based upon the Reviewers comments. Revised grant applications submitted to OHF require a 2-page introduction addressing the Reviewers' comments from the prior review of the grant application. Re-submissions follow the same guidelines and procedures as initial submissions.

Overview | Grant Applications | Funded Grants
Patient Registry | Scientific Advisory Boards